Nanomedicine (Future Medicine journal)

Nanomedicine  
Cover
Discipline Nanomedicine
Language English
Edited by Kostas Kostarelos, Charles R. Martin
Publication details
Publication history
2006–present
Publisher
Frequency Biweekly
4.727
Standard abbreviations
Nanomedicine (Lond.)
Indexing
CODEN NLUKAC
ISSN 1743-5889 (print)
1748-6963 (web)
OCLC no. 503720580
Links

Nanomedicine is a biweekly peer-reviewed medical journal covering research on medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems, and nanorobotics applications in medicine. It was established in 2006 and is published by Future Medicine. The editors-in-chief are Kostas Kostarelos (University of Manchester) and Charles R. Martin (University of Florida).

Abstracting and indexing

The journal is abstracted and indexed in the Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences,[1] Embase/Excerpta Medica,[2] Inspec,[3] Index Medicus/MEDLINE/PubMed, Science Citation Index Expanded,[1] and Scopus.[4] According to the Journal Citation Reports, the journal has a 2016 impact factor of 4.727, ranking it 20th out of 158 journals in the category "Biotechnology & Applied Microbiology"[5] and 24th out of 86 journals in the category "Nanoscience & Nanotechnology".[6]

References

  1. 1 2 "Master Journal List". Intellectual Property & Science. Thomson Reuters. Retrieved 2015-05-16.
  2. "Journal titles covered in Embase". Embase. Elsevier. Retrieved 2015-05-16.
  3. "Inspec list of journals" (PDF). Inspec. Institution of Engineering and Technology. Retrieved 2015-05-16.
  4. "Content overview". Scopus. Elsevier. Retrieved 2015-05-16.
  5. "Journals Ranked by Impact: Biotechnology & Applied Microbiology". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.
  6. "Journals Ranked by Impact: Nanoscience & Nanotechnology". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.